Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Semple, John W ^a,b,c   Kim, Michael ^a,b   Hou, Jing ^a,b   McVey, Mark ^a,b   Lee, Young Jin ^a,b   Tabuchi, Arata ^b   Kuebler, Wolfgang M ^b,c   Chai, Zhong Wei ^a,b   Lazarus, Alan H ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; HUMAN IMMUNOGLOBULIN; REACTIVE OXYGEN METABOLITE; ACID; CXCL2 PROTEIN, MOUSE; IMMUNOGLOBULIN;

ACUTE DRUG ADMINISTRATION; ADVERSE OUTCOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; DYSPNEA; HYPERTENSION; HYPOTHERMIA; IN VITRO STUDY; INJURY SEVERITY; LEUKOCYTE METABOLISM; LUNG ALVEOLUS CELL; LUNG EDEMA; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PROPHYLAXIS; RECTUM TEMPERATURE; RESPIRATORY DISTRESS; SHOCK; SIGNAL TRANSDUCTION; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT DURATION; ACUTE LUNG INJURY; ANIMAL; BAGG ALBINO MOUSE; BLOOD TRANSFUSION; EDEMA; HUMAN; LUNG; METABOLISM; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; SURVIVAL;

ACIDS; ACUTE LUNG INJURY; ANIMALS; BLOOD TRANSFUSION; CHEMOKINE CXCL2; EDEMA; HUMANS; HYPOTHERMIA; IMMUNOGLOBULINS, INTRAVENOUS; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; NEUTROPHILS; REACTIVE OXYGEN SPECIES; SURVIVAL ANALYSIS;

EID: 84857186465     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031357     Document Type: Article

References (57)

1. Chapman CE, Stainsby D, Jones H, Love E, Massey E, et al. (2008) Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 49: 440-452.
2. Food and Drug Administration. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2009. [Accessed June 15, 2011].http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/default.htm.
3. Popovsky MA, Abel MD, Moore SB, (1983) Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Amer Rev Resp Dis 128: 185-189.
4. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, et al. (2001) HLA class II antibodies in transfusion-related acute lung injury. Transfusion 41: 1244-1248.
5. Reil A, Keller-Stanislawski B, Gunay S, Bux J, (2008) Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 95: 313-317.
6. Popovsky MA, Moore SB, (1985) Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25: 573-577.
7. Bux J, Sachs UJ, (2007) The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 136: 788-799.
8. Fung YL, Silliman CC, (2009) The Role of Neutrophils in the Pathogenesis of Transfusion-Related Acute Lung Injury (TRALI). Transfusion Med Rev 23: 266-283.
9. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA, (2002) Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 287: 1968-1971.
10. Nicolle AL, Chapman CE, Carter V, Wallis JP, (2004) Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med 14: 225-230.
11. Jensen S, Jersild C, Grunnet N, (1990) Severe transfusion reaction to donor plasma containing HLA antibody. Vox Sang 59: 62.
12. Win N, Montgomery J, Sage D, Street m, Duncan J, et al. (2001) Recurrent transfusion-related acute lung injury. Transfusion 41: 1421-1425.
13. Shaz BH, Stowell SR, Hillyer CD, (2011) Transfusion-related acute lung injury: from bedside to bench and back. Blood 117: 1463-1471.
14. Vlaar AP, Hofstra JJ, Determann RM, Veelo DP, Paulus F, et al. (2011) The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case control study. Blood 117: 4218-4225.
15. Seeger W, Schneider U, Kreudler B, von Witzleben E, Walmrath D, et al. (1990) Reproduction of Transfusion-related Acute Lung Injury in an Ex Vivo Lung Model. Blood 76: 1438-1444.
16. Sachs UJ, Hattar K, Weissmann N, Bohle RM, Hattar K, et al. (2006) Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 107: 1217-1219.
17. Silliman CC, Voelkel NF, Allard JD, Elzi J, Tuder RM, et al. (1998) Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 101: 1458-1467.
18. Silliman CC, Bjornsen AJ, Wyman TH, Kelher M, Allard J, et al. (2003) Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 43: 633-640.
19. Kelher MR, Masuno T, Moore EE, Damle S, Meng X, et al. (2009) Plasma from stored packed red blood cells and MHC class I antibodies cause acute lung injury in a two-event in vivo rat model. Blood 113: 2079-2087.
20. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA, (2006) Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 116: 1615-1623.
21. Fung YL, Kim M, Tabuchi A, Aslam R, Speck ER, et al. (2010) Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury (TRALI). Blood 116: 3073-3079.
22. Strait RT, Hicks W, Barasa N, Mahler A, Khodoun M, et al. (2011) MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med 208: 2525-2544.
23. Bruton OC, (1952) Aimmunoglobulinemia. Pediatrics 9: 722-735.
24. Ballow M, (2003) Intravenous Immunoglobulins: Clinical Experience and Viral Safety. J Am Pharm Assoc 42: 449-459.
25. Saulsbury FT, Winkelstein JA, Yolken RH, (1980) Chronic rotavirus infection in immunodeficiency. J Pediatrics 97: 61-65.
26. Molica S, Musto P, Chiurazzi F, Specchia G, Brugiatelli M, et al. (1996) Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study. Haematologica 81: 121-126.
27. Imbach P, Barandum S, d'Appuzo V, Baumgartner C, Hirt A, et al. (1981) High-dose intravenous immunoglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228-1231.
28. Bussel J, Lalezari P, Hilgartner M, Partin J, Fikrig S, et al. (1983) Reversal of neutropenia with intravenous immunoglobulin in autoimmune neutropenia of infancy. Blood 62: 398-400.
29. Mueller-Eckhardt C, Salama A, Kiefel V, Neuzner J, et al. (1985) Lack of efficacy of high-dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanism. Scand J Haematol 34: 394-400.
30. Fehr J, Hofmann V, Kappeler U, (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 306: 1254-1258.
31. Samuelsson A, Towers TL, Ravetch JV, (2011) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291: 484-486.
32. Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE, (1984) Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous immunoglobulin. Lancet 2: 765-768.
33. Rossi F, Kazatchkine MD, (1989) Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 143: 4104-4109.
34. Semple JW, Allen D, Hogarth M, Woloski M, David M, et al. (2002) In vivo actions of Anti-D (WinRho SD™) in children with chronic autoimmune thrombocytopenic purpura (ITP). Amer J Hematol 69: 225-227.
35. Cooper N, Heddle NM, deHaas M, Reid ME, Lesser ML, et al. (2004) Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcγRIIa and FcγRIIIa polymorphisms. Brit J Haematol 124: 511-518.
36. Siragam V, Crow AR, Brinc D, Song S, Freedman J, et al. (2004) Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat Med 12: 688-692.
37. Maddur MS, Kaveri SV, Bayry J, (2011) Comparison of different IVIg preparations on IL-17 production by human Th17 cells. Autoimmun Rev 10: 809-10.
38. Maddur MS, Othy S, Hegde P, Vani J, Lacroix-Desmazes S, et al. (2010) Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J Clin Immunol 30 (Suppl 1): S4-8.
39. Navarrete AM, Delignat S, Teillaud JL, Kaveri SV, Lacroix-Desmazes S, Bayry J, (2011) CD4(+)CD25(+) regulatory T cell-mediated changes in the expression of endocytic receptors and endocytosis process of human dendritic cells. Vaccine 29: 2649-52.
40. Rizk A, Gorson KC, Kenney L, Weinstein R, (2001) Transfusion-related acute lung injury after the infusion of IVIG. Transfusion 41: 264-268.
41. Palmer AL, Walker T, Smith JC, (2005) Acute respiratory distress syndrome in a child with Kawasaki disease. South Med J 98: 1031-1033.
42. Berger-Achituv S, Ellis MH, Curtis BR, Wolach B, (2008) Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent. American J Hematol 83: 676-678.
43. Voulgari PV, Paschou S, Svarna E, Tsifetaki N, Drosos AA, (2010) Transfusion-related Acute Lung Injury During Intravenous Immunoglobulin Treatment. J Rheumatol 37: 190-191.
44. Cheema GS, Quismorio FP Jr, (1999) Pulmonary involvement in adult-onset Still's disease. Curr Opin Pulm Med 5: 305-309.
45. Rankin JS, Glower DD, Teichmann TL, Muhlbaier LH, Stratton CW, (2005) Immunotherapy for refractory pulmonary infection after adult cardiac surgery: immune dysregulation syndrome. J Heart Valve Dis 14: 783-791.
46. Cho FN, Chen SN, Kan YY, Lee TC, Wang JS, (2007) Successful management of a pregnant woman with HELLP syndrome, pulmonary edema, postpartum hemorrhage and acute renal failure, using early hemodialysis, intravenous immunoglobulin and noninvasive monitoring: a case report. J Reprod Med 52: 661-663.
47. Tokat O, Kelebek N, Türker G, Kahveci SF, Ozcan B, (2001) Intravenous immunoglobulin in adult varicella pneumonia complicated by acute respiratory distress syndrome. J Int Med Res 29: 252-255.
48. Hagiwara S, Iwasaka H, Hasegawa A, Asai N, Noguchi T, (2008) High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis. Intensive Care Med 34: 1812-1819.
49. Asimakopoulos G, Smith PLC, Ratnatunga CP, Taylor KM, (1999) Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thoracic Surg 68: 1107-1115.
50. Koch C, Li L, Figueroa P, Mihaljevic T, Svensson L, Blackstone EH, (2009) Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg 88: 1410-8.
51. Vlaar AP, Binnekade JM, Prins D, van Stein D, Hofstra JJ, et al. (2010) Risk factors and outcome of transfusion-related acute lung injury in the critically ill: A nested case-control study. Crit Care Med 38: 771-778.
52. Netzer G, Hess JR, (2010) TRALI, transfusion, and acute lung injury: Synergy in action? Crit Care Med 38: 981-982.
53. Macmillan HF, Rowter D, Lee T, Issekutz AC, (2010) Intravenous immunoglobulin G selectively inhibits IL-1α-induced neutrophil-endothelial cell adhesion. Autoimmunity 43: 619-627.
54. Chang J, Shi PA, Chiang EY, Frenette PS, (2008) Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion. Blood 111: 915-923.
55. Takeshita S, Tsujimoto H, Nakatani K, (2005) Intravenous immunoglobulin preparations promote apoptosis in lipopolysaccharide-stimulated neutrophils via an oxygen-dependent pathway in vitro. APMIS 113: 269-277.
56. Wray C, Mao Y, Pan J, Chandrasenal A, Piasta F, et al. (2009) Claudin-4 augments alveolar epithelial barrier function and is induced in acute lung injury. Amer J Physiol Lung Cell Mol Physiol 297: L219-227.
57. Ozato K, Hansen TH, Sachs DH, (1980) Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol 125: 2473-477.